FMP
Diffusion Pharmaceuticals Inc.
DFFN
NASDAQ
Inactive Equity
Diffusion Pharmaceuticals Inc., a biopharmaceutical company, develops novel therapies that enhance the body's ability to deliver oxygen. Its lead product candidate is Trans Sodium Crocetinate that is developed to enhance the diffusion of oxygen to tissues, as well as to treat COVID-19 disease. Diffusion Pharmaceuticals Inc. was founded in 2001 and is based in Charlottesville, Virginia.
4.4 USD
0.41 (9.32%)
Historical Prices
From:
To:
We are unable to load the chart at this time.
About
ceo
Dr. Robert J. Cobuzzi Jr., Ph.D.
sector
Healthcare
industry
Biotechnology
exchange
NASDAQ
Description
Diffusion Pharmaceuticals Inc., a biopharmaceutical company, develops novel therapies that enhance the body's ability to deliver oxygen. Its lead product candidate is Trans Sodium Crocetinate that is developed to enhance the diffusion of oxygen to tissues, as well as to treat COVID-19 disease. Diffusion Pharmaceuticals Inc. was founded in 2001 and is based in Charlottesville, Virginia.
CIK
0001053691
ISIN
US15713L1098
CUSIP
253748305
Address
300 East Main Street
Phone
434 220 0718
Country
US
Employee
13
IPO Date
May 23, 2008
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
DFFN Financial Summary
CIK
0001053691
Exchange
NASDAQ
Industry
Biotechnology
Sector
Healthcare
CUSIP
253748305
ISIN
US15713L1098
Country
US
Price
4.4
Beta
1.76
Volume Avg.
47.81k
Market Cap
8.98M
Shares
-
52-Week
4.139999-14.37
DCF
24.16
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
-0.62
P/B
-
Website
https://www.diffusionpharma.com
Upgrades and Downgrades
We are unable to load this data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest DFFN News
It looks like there's no news available.
